Format

Send to

Choose Destination
J Am Acad Dermatol. 2018 Feb;78(2):419-421. doi: 10.1016/j.jaad.2017.07.059.

Predicting the incidence and timing of central nervous system disease in metastatic melanoma: Implications for surveillance and preventative therapy.

Author information

1
Hofstra-Northwell School of Medicine Uniondale, New York, New York. Electronic address: gdeutsch@northwell.edu.
2
Hofstra-Northwell School of Medicine Uniondale, New York, New York.
3
Brain Tumor Center, New York, New York.
4
Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York.
5
Donald L. Morton, MD, Melanoma Research Program, New York, New York.
PMID:
29332716
PMCID:
PMC5783312
DOI:
10.1016/j.jaad.2017.07.059
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center